HIM
NXTC icon

Hillhouse Investment Management’s NextCure NXTC Stock Holding History

Hillhouse Investment Management’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$14.7M Buy
+81,548
New +$17M 0.47% 25

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hillhouse Investment Management's NXTC Position: Q2 2019 in Review

Hillhouse Investment Management opened a new position in NextCure (NXTC) in Q2 2019: 81,548 shares worth $14.7M. The stake represents 0.47% of the portfolio and ranks #25 among its holdings.

44 funds tracked by Wall St. Rank hold NXTC as of Q2 2019.

  • Hillhouse Investment Management held 81,548 shares of NextCure worth $14.7M as of Q2 2019.
  • NextCure was a new Hillhouse Investment Management position in Q2 2019.
  • NextCure made up 0.47% of Hillhouse Investment Management's portfolio in Q2 2019, its #25 holding.
  • 44 funds tracked by Wall St. Rank held NextCure as of Q2 2019.

Based on Hillhouse Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.